1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with HIV in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayani, KC; Pitrak, DL; Verral, SC | 1 |
| Epstein, LG; Kieburtz, K; Marder, K; McArthur, JC; McDermott, MP; Sacktor, N; Schifitto, G; Small, S | 1 |
| Bensaid, O; Clayette, P; Dereuddre-Bosquet, N; Dong, CZ; Dormont, D; Godfroid, JJ; Heymans, F; Huet, J; Kan, E; Lamouri, A; Martin, M; Redeuilh, C; Serradji, N | 1 |
| Bazan, NG; Block, AL; Braquet, P; Squinto, SP | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and HIV
| Article | Year |
|---|---|
Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.
Topics: Adult; Cognition Disorders; Double-Blind Method; Female; HIV; Humans; Imidazoles; Leucine; Male; Middle Aged; Neuropsychological Tests; Platelet Activating Factor | 1999 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and HIV
| Article | Year |
|---|---|
Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children.
Topics: Adolescent; Analysis of Variance; Child; Child, Preschool; Complement System Proteins; Female; HIV; HIV Infections; Humans; Immunity, Innate; In Vitro Techniques; Luminescent Measurements; Male; Peroxidase; Phagocytes; Platelet Activating Factor; Reference Values; Respiratory Burst; Risk Factors | 1999 |
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication.
Topics: Anti-HIV Agents; Cells, Cultured; HIV; Humans; In Vitro Techniques; Inhibitory Concentration 50; Macrophages; Microbial Sensitivity Tests; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thiazoles; Virus Replication | 2000 |
Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Design; Gene Expression Regulation, Viral; Genes, Viral; HIV; Humans; Leukemia-Lymphoma, Adult T-Cell; Neuroblastoma; Platelet Activating Factor; Promoter Regions, Genetic; Recombinant Fusion Proteins; Repetitive Sequences, Nucleic Acid; Stimulation, Chemical; T-Lymphocytes; Transfection; Tumor Cells, Cultured | 1990 |